Novartis Teams Up With Legend, Moving CAR-T Into Solid Tumors

 
• By Alaric DeArment
Novartis signed a licensing deal with Legend Biotech for its DLL3-directed CAR-T therapy candidates. • Source: Shutterstock

More from Deals

More from Business